Opus Point Partners’ AUM, History and Investments

3. AstraZeneca plc (ADR) (NYSE:AZN)

Opus Point also held 120,000 shares of AstraZeneca plc (ADR) (NYSE:AZN) heading into the third quarter; the value of the stake was $4.09 million at the end of June. Another investor bullish on AstraZeneca plc (ADR) (NYSE:AZN) is Fisher Asset Management, which boosted its stake more than fourfold during the second quarter and holds 11.08 million shares.

The company’s stock jumped in May following positive late-stage results from its Phase 3 study of durvalumab for the treatment of non-small cell lung cancer, but it plunged at the end of July on the back of disappointing second-quarter results. In this way, AstraZeneca plc (ADR) (NYSE:AZN)’s stock is around 7% in the green year-to-date and sports a dividend yield of 4.80%.